| Q33719810 | A Hyper-Crosslinked Carbohydrate Polymer Scaffold Facilitates Lineage Commitment and Maintains a Reserve Pool of Proliferating Cardiovascular Progenitors |
| Q34116906 | A crucial role of activin A-mediated growth hormone suppression in mouse and human heart failure |
| Q37483053 | A heart full of stem cells: the spectrum of myocardial progenitor cells in the postnatal heart |
| Q40046071 | A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cells. |
| Q36274962 | A novel two-step procedure to expand cardiac Sca-1+ cells clonally. |
| Q36756907 | A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells |
| Q34644098 | Abi3bp regulates cardiac progenitor cell proliferation and differentiation |
| Q55027718 | Activation of Endogenous Cardiac Stem Cells by Apelin-13 in Infarcted Rat Heart. |
| Q36943965 | Activation of endothelial nitric oxide synthase is critical for erythropoietin-induced mobilization of progenitor cells |
| Q36789008 | Acute myocardial infarction induced functional cardiomyocytes to re-enter the cell cycle |
| Q41976027 | Adenosine A2B receptors on cardiac stem cell antigen (Sca)-1-positive stromal cells play a protective role in myocardial infarction. |
| Q64264854 | Adult Cardiac Stem Cell Aging: A Reversible Stochastic Phenomenon? |
| Q47097822 | Adult cardiac stem cells are multipotent and robustly myogenic: c-kit expression is necessary but not sufficient for their identification |
| Q36815983 | Adult stem cells and heart regeneration |
| Q37815089 | Adult stem cells: from new cell sources to changes in methodology |
| Q38344723 | Allogeneic cardiac stem cell administration for acute myocardial infarction |
| Q35114912 | Anti-inflammatory peptides from cardiac progenitors ameliorate dysfunction after myocardial infarction |
| Q42410417 | Apoptosis-Resistant Cardiac Progenitor Cells Modified With Apurinic/Apyrimidinic Endonuclease/Redox Factor 1 Gene Overexpression Regulate Cardiac Repair After Myocardial Infarction |
| Q38587005 | Biomimetic approaches for cell implantation to the restoration of infarcted myocardium |
| Q28251098 | Bone marrow stem cell transplantation for cardiac repair |
| Q37293770 | Bone marrow-derived cells can acquire cardiac stem cells properties in damaged heart |
| Q41880515 | Bone-marrow-derived side population cells for myocardial regeneration |
| Q41813361 | C-Kit Promotes Growth and Migration of Human Cardiac Progenitor Cells via the PI3K-AKT and MEK-ERK Pathways |
| Q50668745 | C-kit+ cardiac progenitors exhibit mesenchymal markers and preferential cardiovascular commitment. |
| Q42491583 | Cancer stem cells and microenvironment in prostate cancer progression |
| Q90910984 | Cardiac Pacemaker Cells Generate Cardiomyocytes from Fibroblasts in Long-Term Cultures |
| Q42718220 | Cardiac Progenitor Cells and the Interplay with Their Microenvironment |
| Q91643965 | Cardiac Progenitor Cells from Stem Cells: Learning from Genetics and Biomaterials |
| Q55085484 | Cardiac Progenitor Cells in Basic Biology and Regenerative Medicine. |
| Q90632565 | Cardiac Sca-1+ Cells Are Not Intrinsic Stem Cells for Myocardial Development, Renewal, and Repair |
| Q37050454 | Cardiac Stem Cell Secretome Protects Cardiomyocytes from Hypoxic Injury Partly via Monocyte Chemotactic Protein-1-Dependent Mechanism |
| Q37800141 | Cardiac cell therapies: the next generation |
| Q37092180 | Cardiac cell-based therapy: cell types and mechanisms of actions |
| Q37767677 | Cardiac progenitor cells: potency and control |
| Q38079141 | Cardiac progenitor/stem cells on myocardial infarction or ischemic heart disease: what we have known from current research |
| Q34643788 | Cardiac regenerative capacity and mechanisms |
| Q37253735 | Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease |
| Q33270812 | Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo |
| Q36267790 | Cardiac stem cells and mechanisms of myocardial regeneration |
| Q38067273 | Cardiac stem cells and their roles in myocardial infarction |
| Q33928468 | Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function |
| Q38673647 | Cardiac stem cells for myocardial regeneration: promising but not ready for prime time |
| Q38112116 | Cardiac stem cells in patients with heart disease |
| Q36603788 | Cardiac stem cells: A promising treatment option for heart failure |
| Q26825051 | Cardiac stem cells: biology and clinical applications |
| Q79579848 | Cardiac stem cells: isolation, expansion and experimental use for myocardial regeneration |
| Q39310120 | Cardiac stem cells: translation to human studies. |
| Q27025973 | Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications |
| Q37766199 | Cardiogenesis: an embryological perspective. |
| Q38588589 | Cardiomyocyte regeneration |
| Q36309565 | Cardiomyocytes derived from stem cells |
| Q42916219 | Cardiomyocytes fuse with surrounding noncardiomyocytes and reenter the cell cycle |
| Q37002682 | Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis |
| Q89470758 | Cardioprotective effects of genetically engineered cardiac stem cells by spheroid formation on ischemic cardiomyocytes |
| Q36709853 | Cardiosphere-derived cells from pediatric end-stage heart failure patients have enhanced functional activity due to the heat shock response regulating the secretome |
| Q38662414 | Cell models of arrhythmogenic cardiomyopathy: advances and opportunities |
| Q38145165 | Cell shape and cardiosphere differentiation: a revelation by proteomic profiling. |
| Q38095938 | Cell therapy for cardiovascular diseases |
| Q27001159 | Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions |
| Q37776514 | Cell therapy for heart failure: the need for a new therapeutic strategy |
| Q37206495 | Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells |
| Q36667275 | Cell-based approaches for cardiac repair |
| Q46065832 | Cellular ELF signals as a possible tool in informative medicine |
| Q41619434 | Cellular and molecular characterization of human cardiac stem cells reveals key features essential for their function and safety. |
| Q37514676 | Cellular cardiomyoplasty: what have we learned? |
| Q35808738 | Challenges for heart disease stem cell therapy |
| Q28083859 | Challenges in identifying the best source of stem cells for cardiac regeneration therapy |
| Q57072502 | Changing Metabolism in Differentiating Cardiac Progenitor Cells-Can Stem Cells Become Metabolically Flexible Cardiomyocytes? |
| Q54387184 | Characterisation and cardiac directed differentiation of canine adult cardiac stem cells. |
| Q34562292 | Characterization of epicardial-derived cardiac interstitial cells: differentiation and mobilization of heart fibroblast progenitors |
| Q48561642 | Collagen-binding VEGF targeting the cardiac extracellular matrix promotes recovery in porcine chronic myocardial infarction |
| Q27021931 | Concise review: heart regeneration and the role of cardiac stem cells |
| Q37325205 | Coronary adventitial cells are linked to perivascular cardiac fibrosis via TGFβ1 signaling in the mdx mouse model of Duchenne muscular dystrophy |
| Q34427072 | Coronary microvascular dysfunction in diabetes mellitus: A review |
| Q36722039 | Creation of a biological pacemaker by gene- or cell-based approaches |
| Q48601122 | Cryopreservation of canine cardiosphere-derived cells: Implications for clinical application |
| Q54945960 | Current Trends in Biomaterial Utilization for Cardiopulmonary System Regeneration. |
| Q34271595 | De novo myocardial regeneration: advances and pitfalls |
| Q37835598 | Developmental and regenerative biology of multipotent cardiovascular progenitor cells |
| Q36225114 | Differentiation pathways in human embryonic stem cell-derived cardiomyocytes |
| Q36958843 | Differentiation-Associated MicroRNA Alterations in Mouse Heart-Derived Sca-1(+)CD31(-) and Sca-1(+)CD31(+) Cells |
| Q35799278 | Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells |
| Q30731784 | Direct hydrogel encapsulation of pluripotent stem cells enables ontomimetic differentiation and growth of engineered human heart tissues |
| Q36853973 | Dissecting the molecular relationship among various cardiogenic progenitor cells |
| Q48033062 | Distinct patterns of histone modifications at cardiac-specific gene promoters between cardiac stem cells and mesenchymal stem cells |
| Q59133041 | Does cardiac development provide heart research with novel therapeutic approaches? |
| Q48487014 | Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathy |
| Q34053605 | Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells |
| Q37653423 | Electrophysiological challenges of cell-based myocardial repair |
| Q39624485 | Embryonic stem cell-derived cardiomyocytes harbor a subpopulation of niche-forming Sca-1+ progenitor cells |
| Q37235964 | Endothelial cell lineages of the heart |
| Q39699715 | Endothelial cells regulate cardiomyocyte development from embryonic stem cells |
| Q55287570 | Engineering Scalable Manufacturing of High-Quality Stem Cell-Derived Cardiomyocytes for Cardiac Tissue Repair. |
| Q36772688 | Enhanced efficiency of genetic programming toward cardiomyocyte creation through topographical cues |
| Q38129288 | Fate choice of post-natal mesoderm progenitors: skeletal versus cardiac muscle plasticity |
| Q34103190 | Foetal and adult cardiomyocyte progenitor cells have different developmental potential |
| Q26770469 | From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders |
| Q36569726 | From cardiac repair to cardiac regeneration--ready to translate? |
| Q28272593 | From embryonic stem cells to blastema and MRL mice |
| Q40107286 | Functional arginine vasopressin system in early heart maturation |
| Q43174614 | Functional ion channels in mouse cardiac c-kit(+) cells |
| Q81424114 | G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes |
| Q61865123 | Growth-factor-mediated cardiac stem cell activation in myocardial regeneration |
| Q38018889 | Harnessing the potential of adult cardiac stem cells: lessons from haematopoiesis, the embryo and the niche |
| Q87039093 | Heart Regeneration with Embryonic Cardiac Progenitor Cells and Cardiac Tissue Engineering |
| Q57395528 | Heart failure and regenerative cardiology |
| Q34390677 | Heart regeneration: Past, present and future |
| Q36606663 | Heart repair and stem cells |
| Q34009778 | Heterogeneity in SDF-1 expression defines the vasculogenic potential of adult cardiac progenitor cells |
| Q93120633 | Heterogeneity of Adult Cardiac Stem Cells |
| Q39777378 | High-resolution X-ray microtomography for three-dimensional imaging of cardiac progenitor cell homing in infarcted rat hearts |
| Q34091031 | Human cardiac stem cells isolated from atrial appendages stably express c-kit |
| Q37023827 | Human embryonic stem cells and cardiac repair |
| Q41548516 | Hypoxic Stress Decreases c-Myc Protein Stability in Cardiac Progenitor Cells Inducing Quiescence and Compromising Their Proliferative and Vasculogenic Potential |
| Q37372976 | Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression |
| Q37386990 | IFATS collection: Stem cell antigen-1-positive ear mesenchymal stem cells display enhanced adipogenic potential |
| Q34043019 | Identification and characterization of a novel multipotent sub-population of Sca-1⁺ cardiac progenitor cells for myocardial regeneration |
| Q30836430 | Identification of cardiac progenitors that survive in the ischemic human heart after ventricular myocyte death. |
| Q41915295 | Identification of functional tissue-resident cardiac stem/progenitor cells in adult mouse |
| Q30494736 | Imaging survival and function of transplanted cardiac resident stem cells |
| Q36737033 | Immune response to stem cells and strategies to induce tolerance |
| Q39651637 | Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction |
| Q38671887 | Improved Method for Isolation of Neonatal Rat Cardiomyocytes with Increased Yield of C-Kit+ Cardiac Progenitor Cells |
| Q38088809 | Improvement of cardiac efficacy and safety models in drug discovery by the use of stem cell-derived cardiomyocytes |
| Q36819462 | Inhibition of Wnt6 by Sfrp2 regulates adult cardiac progenitor cell differentiation by differential modulation of Wnt pathways |
| Q34501242 | Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy |
| Q43676834 | Intrinsic cardiac origin of human cardiosphere-derived cells |
| Q34271019 | Ischemia-reperfusion injury and pregnancy initiate time-dependent and robust signs of up-regulation of cardiac progenitor cells |
| Q61436076 | Ischemic survival and constitutively active autophagy in self-beating atypically-shaped cardiomyocytes (ACMs): characterization of a new subpopulation of heart cells |
| Q34048791 | Isolation and characterization of a Sca-1+/CD31- progenitor cell lineage derived from mouse heart tissue |
| Q34774577 | Isolation and characterization of mouse bone marrow-derived Lin⁻/VEGF-R2⁺ progenitor cells |
| Q36691627 | Isolation and expansion of resident cardiac progenitor cells. |
| Q57578159 | Isolation, Characterization and Differentiation Potential of Cardiac Progenitor Cells in Adult Pigs |
| Q38140885 | JAK-STAT signaling in cardiomyogenesis of cardiac stem cells |
| Q50589159 | Left atrium of the human adult heart contains a population of side population cells. |
| Q50949064 | Leukemia inhibitory factor induces endothelial differentiation in cardiac stem cells. |
| Q33985922 | Local activation of cardiac stem cells for post-myocardial infarction cardiac repair |
| Q37355668 | Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function |
| Q28262163 | Localization of Islet-1-positive cells in the healthy and infarcted adult murine heart |
| Q37506545 | Lost in translation: what is limiting cardiomyoplasty and can tissue engineering help? |
| Q26773016 | Mesenchymal Stromal Cells and Tissue-Specific Progenitor Cells: Their Role in Tissue Homeostasis |
| Q37576616 | Mesenchymal stem cells from umbilical cord tissue as potential therapeutics for cardiomyodegenerative diseases - a review |
| Q36565103 | MiR218 Modulates Wnt Signaling in Mouse Cardiac Stem Cells by Promoting Proliferation and Inhibiting Differentiation through a Positive Feedback Loop |
| Q38066135 | Migration of resident cardiac stem cells in myocardial infarction |
| Q88970178 | Molecular basis of functional myogenic specification of Bona Fide multipotent adult cardiac stem cells |
| Q37808269 | Molecular physiology of cardiac regeneration |
| Q55365025 | Molecular signature of progenitor cells isolated from young and adult human hearts. |
| Q30595510 | Mouse adipose tissue stromal cells give rise to skeletal and cardiomyogenic cell sub-populations. |
| Q28085334 | Multipotent stem cells of the heart-do they have therapeutic promise? |
| Q38632039 | Myocardial infarction: stem cell transplantation for cardiac regeneration. |
| Q33853869 | Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure |
| Q38045804 | Myocardial regeneration of the failing heart |
| Q36710761 | Myocyte death and renewal: modern concepts of cardiac cellular homeostasis. |
| Q38738993 | Navigating the labyrinth of cardiac regeneration |
| Q41955267 | Nestin expression in end-stage disease in dystrophin-deficient heart: implications for regeneration from endogenous cardiac stem cells |
| Q43035200 | Neuroendocrine and cardiovascular parameters during simulation of stress-induced rise in circulating oxytocin in the rat. |
| Q28565088 | Notch1 signaling stimulates proliferation of immature cardiomyocytes |
| Q38717572 | Novel molecular mechanisms and regeneration therapy for heart failure |
| Q28305555 | Novel therapy for myocardial infarction: can HGF/Met be beneficial? |
| Q34688306 | Optimised protocols for the identification of the murine cardiac side population. |
| Q38017961 | Optimizing cardiac repair and regeneration through activation of the endogenous cardiac stem cell compartment |
| Q37766810 | Origin of cardiac progenitor cells in the developing and postnatal heart |
| Q24561974 | Oxytocin in cardiac ontogeny |
| Q37689872 | Oxytocin: Old Hormone, New Drug |
| Q35775407 | PDGFRα demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium |
| Q51746264 | Polycaprolactone-thiophene-conjugated carbon nanotube meshes as scaffolds for cardiac progenitor cells. |
| Q104070079 | Precision medicine for heart failure based on molecular mechanisms The Research Achievement Award Lecture |
| Q58816086 | Pressure overload leads to an increase of cardiac resident stem cells |
| Q53407725 | Priming of mesenchymal stem cells with oxytocin enhances the cardiac repair in ischemia/reperfusion injury. |
| Q30604339 | Prion protein- and cardiac troponin T-marked interstitial cells from the adult myocardium spontaneously develop into beating cardiomyocytes. |
| Q37595834 | Progenitor cell therapy for heart disease |
| Q26823933 | Programming and reprogramming a human heart cell |
| Q36841204 | Prolactin mediates effects of chronic psychological stress on induction of fibrofatty cells in the heart |
| Q39242509 | Protein O-GlcNAcylation is a novel cytoprotective signal in cardiac stem cells |
| Q46491805 | Purification and characterization of mouse fetal liver epithelial cells with high in vivo repopulation capacity |
| Q39827447 | Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer |
| Q52724095 | Reactivation of the Nkx2.5 cardiac enhancer after myocardial infarction does not presage myogenesis. |
| Q38226891 | Redox signaling in cardiac renewal |
| Q27687840 | Regenerating functional heart tissue for myocardial repair |
| Q45882958 | Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells |
| Q47744623 | Regenerative Stem Cell Therapy Optimization via Tissue Engineering in Heart Failure with Reduced Ejection Fraction |
| Q36462071 | Regenerative medicine for cardiovascular disorders-new milestones: adult stem cells |
| Q34399774 | Regenerative medicine for the heart: perspectives on stem-cell therapy |
| Q37360489 | Regenerative therapy and tissue engineering for the treatment of end-stage cardiac failure: new developments and challenges |
| Q38174769 | Regenerative therapy for cardiovascular disease |
| Q36410447 | Renovation of the injured heart with myocardial tissue engineering |
| Q37774067 | Resident cardiac progenitor cells: at the heart of regeneration. |
| Q36406477 | Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration. |
| Q36406482 | Resident progenitors and bone marrow stem cells in myocardial renewal and repair |
| Q34984962 | Restoration of angiogenic capacity of diabetes-insulted mesenchymal stem cells by oxytocin |
| Q35996708 | Role of A2B adenosine receptors in regulation of paracrine functions of stem cell antigen 1-positive cardiac stromal cells |
| Q34123206 | Role of adenosine A2B receptor signaling in contribution of cardiac mesenchymal stem-like cells to myocardial scar formation. |
| Q91638361 | Role of c-Kit in Myocardial Regeneration and Aging |
| Q26858965 | Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology |
| Q46638341 | Role of sarcolemmal ATP-sensitive K+ channels in the regulation of sinoatrial node automaticity: an evaluation using Kir6.2-deficient mice |
| Q33809635 | Role of stem cells in cardiovascular biology |
| Q37644732 | SCA-1 Labels a Subset of Estrogen-Responsive Bipotential Repopulating Cells within the CD24+ CD49fhi Mammary Stem Cell-Enriched Compartment |
| Q54588400 | STAT3/Pim-1 signaling pathway plays a crucial role in endothelial differentiation of cardiac resident Sca-1+ cells both in vitro and in vivo. |
| Q33821738 | Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. |
| Q41039045 | Sca-1 identifies a trophoblast population with multipotent potential in the mid-gestation mouse placenta. |
| Q34110874 | Sca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusion |
| Q34137691 | Sca-1+ cardiosphere-derived cells are enriched for Isl1-expressing cardiac precursors and improve cardiac function after myocardial injury |
| Q43747046 | Sca-1-positive cardiac stem cell migration in a cardiac infarction model |
| Q37344589 | Sca1-derived cells are a source of myocardial renewal in the murine adult heart. |
| Q50550784 | Scaffold-free and scaffold-assisted 3D culture enhances differentiation of bone marrow stromal cells. |
| Q33867517 | Self-beating atypically shaped cardiomyocytes survive a long-term postnatal development while preserving the expression of fetal cardiac genes in mice |
| Q79508895 | Single-cell-derived mesenchymal stem cells overexpressing Csx/Nkx2.5 and GATA4 undergo the stochastic cardiomyogenic fate and behave like transient amplifying cells |
| Q90492121 | Smooth Muscle Differentiation of Penile Stem/Progenitor Cells Induced by Microenergy Acoustic Pulses In Vitro |
| Q92701228 | Spontaneously Formed Spheroids from Mouse Compact Bone-Derived Cells Retain Highly Potent Stem Cells with Enhanced Differentiation Capability |
| Q30492259 | Spontaneously beating cardiomyocytes derived from white mature adipocytes. |
| Q26785527 | Stem Cells and Progenitor Cells for Tissue-Engineered Solutions to Congenital Heart Defects |
| Q50075212 | Stem Cells in Regenerative Cardiology |
| Q27026285 | Stem cell mechanisms during left ventricular remodeling post-myocardial infarction: Repair and regeneration |
| Q34657903 | Stem cell niches in the adult mouse heart |
| Q34129904 | Stem cell therapy for cardiac dysfunction |
| Q40097837 | Stem cell therapy for heart failure: the science and current progress. |
| Q39850212 | Stem cell therapy for ischemic heart disease |
| Q34026311 | Stem cell therapy for pediatric dilated cardiomyopathy |
| Q33348580 | Stem cell therapy: pieces of the puzzle |
| Q37766151 | Stem cells and cardiac repair: a critical analysis |
| Q38273056 | Stem cells for cardiac regeneration and possible roles of the transforming growth factor-β superfamily |
| Q40006145 | Stem cells from in- or outside of the heart: isolation, characterization, and potential for myocardial tissue regeneration |
| Q33863225 | Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function |
| Q37153062 | Stem cells in the heart: what's the buzz all about?--Part 1: preclinical considerations |
| Q37255265 | Stemming heart failure with cardiac- or reprogrammed-stem cells |
| Q34372277 | Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction |
| Q38537491 | Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review |
| Q43071534 | TGF-beta1 enhances cardiomyogenic differentiation of skeletal muscle-derived adult primitive cells |
| Q92311732 | TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease |
| Q37227430 | TNF, acting through inducibly expressed TNFR2, drives activation and cell cycle entry of c-Kit+ cardiac stem cells in ischemic heart disease |
| Q57169628 | The Biological Mechanisms of Action of Cardiac Progenitor Cell Therapy |
| Q28080565 | The Role of MicroRNAs in Cardiac Stem Cells |
| Q51996724 | The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells. |
| Q36174197 | The bone marrow--cardiac axis of myocardial regeneration |
| Q43139216 | The effects of DNA methyltransferase inhibitors and histone deacetylase inhibitors on digit regeneration in mice |
| Q37625460 | The existence of myocardial repair: mechanistic insights and enhancements |
| Q37790961 | The future of regenerating the myocardium |
| Q39300767 | The hypothalamic neuropeptide oxytocin is required for formation of the neurovascular interface of the pituitary |
| Q84080482 | The hypoxic epicardial and subepicardial microenvironment |
| Q38019033 | The many faces of p38 mitogen-activated protein kinase in progenitor/stem cell differentiation. |
| Q37766123 | The paracrine effect: pivotal mechanism in cell-based cardiac repair |
| Q37325686 | The potential of stem cells in the treatment of cardiovascular diseases |
| Q37696788 | The role of oxytocin in cardiovascular regulation |
| Q34405511 | The role of stem cells in cardiac regeneration. |
| Q84857807 | The subpopulation of mesenchymal stem cells that differentiate toward cardiomyocytes is cardiac progenitor cells |
| Q36909360 | Therapeutic potential of adult progenitor cells in cardiovascular disease |
| Q37887539 | Tissue engineering and cell-based therapy toward integrated strategy with artificial organs |
| Q42957210 | Tissue-resident Sca1+ PDGFRα+ mesenchymal progenitors are the cellular source of fibrofatty infiltration in arrhythmogenic cardiomyopathy |
| Q51549947 | Transplantation of Marrow-Derived Cardiac Stem Cells Carried in Fibrin Improves Cardiac Function After Myocardial Infarction |
| Q37286681 | Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice |
| Q57821546 | Two mechanisms of cardiac stem cell-mediated cardiomyogenesis in the adult mammalian heart include formation of colonies and cell-in-cell structures |
| Q33683767 | Unchain my heart: the scientific foundations of cardiac repair |
| Q53519759 | Uterine-derived progenitor cells are immunoprivileged and effectively improve cardiac regeneration when used for cell therapy. |
| Q90211066 | Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review |
| Q37007214 | Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications |
| Q37812214 | Wnt Signaling and Aging-Related Heart Disorders |
| Q47131900 | c-kit Positive Cardiac Outgrowth Cells Demonstrate Better Ability for Cardiac Recovery Against Ischemic Myopathy |
| Q27315833 | c-kitpos GATA-4 high rat cardiac stem cells foster adult cardiomyocyte survival through IGF-1 paracrine signalling |
| Q28590593 | β-arrestin2/miR-155/GSK3β regulates transition of 5'-azacytizine-induced Sca-1-positive cells to cardiomyocytes |